Osaic Holdings’s Pandion Therapeutics Inc. Common Stock PAND Stock Holding History

Osaic Holdings’s Portfolio PAND Stock Details PAND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-39	Closed	-$2K	–	7336
2021 Q1	$2K	Buy	39 +24	+160%	+$869	﹤0.01%	6588
2020 Q4	$0	Sell	15 -335	-96%	-$4.66K	﹤0.01%	6734
2020 Q3	$4K	Buy	+350	New	+$5.98K	﹤0.01%	5687

Osaic Holdings's PAND Position: Q2 2021 in Review

Osaic Holdings sold out of Pandion Therapeutics Inc. Common Stock (PAND) in Q2 2021, closing a stake of 39 shares — an estimated $2K sold.

Osaic Holdings first reported a position in PAND in Q3 2020 and held it in 3 quarters. The position peaked at $4K in Q3 2020. 0 funds tracked by Wall St. Rank hold PAND as of Q2 2021.

Osaic Holdings reported no remaining Pandion Therapeutics Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
Osaic Holdings sold 39 Pandion Therapeutics Inc. Common Stock shares in Q2 2021, an estimated $2K.
Osaic Holdings first reported a position in Pandion Therapeutics Inc. Common Stock in Q3 2020 and held it in 3 quarters.
Osaic Holdings's Pandion Therapeutics Inc. Common Stock position peaked at $4K in Q3 2020.
0 funds tracked by Wall St. Rank held Pandion Therapeutics Inc. Common Stock as of Q2 2021.

Based on Osaic Holdings's 13F filing for Q2 2021, filed 2 Aug 2021.